Skip to content

Comparison of the effect between long-limb and conventional bypass reconstruction after subtotal gastrectomy in gastric cancer patients with type II diabetes (Multicenter Prospective Randomized Controlled Study)

Comparison of the effect between long-limb and conventional bypass reconstruction after subtotal gastrectomy in gastric cancer patients with type II diabetes (Multicenter Prospective Randomized Controlled Study)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0004669
Enrollment
94
Registered
2020-01-29
Start date
2020-07-07
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : If selected as a research group, you will undergo surgery to extend the length of the boughs of the wild and the raw eggplant to 80 centimeters each, as shown in the figure below.

Sponsors

Koera University Guro Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Gastric cancer patients who are scheduled to undergo laparoscopic or lower robotic gastrectomy diagnosed with stage 1 clinical stage before surgery (including patients who need additional chemotherapy, etc. according to postoperative pathology) ? Patients aged 20 to under 80 ? A history of suspected or diagnosed type 2 diabetes prior to surgery ? Body Mass Index (BMI) 23 or higher before surgery ? If sufficient explanation of possible risks during preoperative clinical research is heard and agreed

Exclusion criteria

Exclusion criteria: ? You have a history of cancer other than stomach cancer in the last 5 years ? In the case of chemotherapy treatment before gastric cancer surgery ? In the case of preoperative progressive gastric cancer or gastrectomy located in the upper part ? If you have a history of impaired absorption

Design outcomes

Primary

MeasureTime frame
IMprovement: Transitioning from insulin injection to oral blood glucose drop and reducing the dosage of diabetes drugs

Secondary

MeasureTime frame
Partial remission: 100 to 125 per empty blood without taking diabetes drugs, and 6.4 per cent of glycoprotein 6

Countries

Korea, Republic of

Contacts

Public ContactHAM WOOK

Koera University Guro Hospital

wookstore@daum.net+82-2-2626-1147

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: May 1, 2026